A Bioactive Synthetic Outer-core Oligosaccharide Derived from a Klebsiella pneumonia Lipopolysaccharide for Bacteria Recognition

Keyphrases

• Lipopolysaccharide 100%
• Pneumonia 100%
• Klebsiella Pneumoniae (K. pneumoniae) 100%
• Oligosaccharides 100%
• Bioactive 100%
• Outer Core Oligosaccharide 100%
• Bacteria Recognition 100%
• New Treatment Options 50%
• Linker 50%
• Life-threatening 50%
• Hydroxyl 50%
• Common Cause 50%
• Conjugation 50%
• Human Use 50%
• Chemical Synthesis 50%
• Carrier Protein 50%
• Community-acquired Infections 50%
• Amino 50%
• Amines 50%
• Therapeutic Vaccination 50%
• TETRA 50%
• Glycoconjugate Vaccines 50%
• Vaccine Candidate 50%
• Protecting Groups 50%
• Tetrasaccharide 50%
• Outer Core 50%
• Hospital-acquired Infection 50%
• Pentasaccharide 50%
• Monosaccharide Building Blocks 50%
• Klebsiella Pneumoniae Carbapenemase 50%
• Prophylactic Vaccination 50%
• CRM197 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Lipopolysaccharide 100%
• Klebsiella pneumoniae 100%
• Oligosaccharide 100%
• Mouse 33%
• Carbon Tetrachloride 33%
• Hospital Infection 33%
• Carbapenem 33%
• Infection 33%
• Community Acquired Infection 33%
• Monosaccharide 33%
• Carrier Protein 33%
• Bovine Serum Albumin 33%
• Tetrasaccharide 33%
• Pentasaccharide 33%
• Diphtheria Toxoid CRM197 33%
• Vaccination Policy 33%
• Glycoconjugate 33%

Immunology and Microbiology

• Klebsiella pneumoniae 100%
• Monospecific Antibody 33%
• Vaccine Efficacy 33%
• Membrane Transport Protein 33%
• Synthesis 33%
• Mouse 33%
• Diphtheria Toxoid CRM197 33%
• Vaccination Policy 33%
• Glycoconjugate 33%